Literature DB >> 1373272

Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method.

R W Shin1, T Iwaki, T Kitamoto, Y Sato, J Tateishi.   

Abstract

Using the hydrated autoclaving method, a new immunohistochemical procedure to enhance tau immunoreactivity in formalin-fixed brain tissue, the authors recently reported that tau protein is detected in neuronal cell bodies and proximal dendrites, gray matter neuropil, axons, and glial cells in normal human hippocampus and neocortex. In the this study, the authors performed a comparative study of the distribution of normal and modified forms of tau in Alzheimer's disease (AD) and control brains. In the cerebral cortex and white matter of AD brains, a massive accumulation of modified tau and/or severe depletion of normal tau were documented in all the tau compartments. In mild AD cases, gray matter neuropil, axons, and glial cells were less severely involved than neuronal perikarya. In the controls, neuronal perikarya were often involved by modified tau accumulation, but the other compartments showed normal distribution. These observations suggest that modifications of tau which lead to neurofibrillary lesions in AD may begin in neuronal perikarya and extend to the other tau compartments in advanced stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373272      PMCID: PMC1886360     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques.

Authors:  H Braak; E Braak; I Grundke-Iqbal; K Iqbal
Journal:  Neurosci Lett       Date:  1986-04-24       Impact factor: 3.046

2.  A neuronal antigen in the brains of Alzheimer patients.

Authors:  B L Wolozin; A Pruchnicki; D W Dickson; P Davies
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

3.  Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.

Authors:  A Delacourte; S Flament; E M Dibe; P Hublau; B Sablonnière; B Hémon; V Shérrer; A Défossez
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum.

Authors:  J P Brion; J Guilleminot; D Couchie; J Flament-Durand; J Nunez
Journal:  Neuroscience       Date:  1988-04       Impact factor: 3.590

5.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

6.  Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment.

Authors:  K S Kosik; J E Crandall; E J Mufson; R L Neve
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

7.  Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1.

Authors:  H Ksiezak-Reding; L I Binder; S H Yen
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

8.  Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.

Authors:  S C Papasozomenos
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

9.  Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.

Authors:  N W Kowall; K S Kosik
Journal:  Ann Neurol       Date:  1987-11       Impact factor: 10.422

10.  Epitopes that span the tau molecule are shared with paired helical filaments.

Authors:  K S Kosik; L D Orecchio; L Binder; J Q Trojanowski; V M Lee; G Lee
Journal:  Neuron       Date:  1988-11       Impact factor: 17.173

View more
  13 in total

1.  Amyloid-beta induced retrograde axonal degeneration in a mouse tauopathy model.

Authors:  Christopher Nishioka; Hsiao-Fang Liang; Barsam Barsamian; Shu-Wei Sun
Journal:  Neuroimage       Date:  2019-01-07       Impact factor: 6.556

2.  Lithium suppression of tau induces brain iron accumulation and neurodegeneration.

Authors:  P Lei; S Ayton; A T Appukuttan; S Moon; J A Duce; I Volitakis; R Cherny; S J Wood; M Greenough; G Berger; C Pantelis; P McGorry; A Yung; D I Finkelstein; A I Bush
Journal:  Mol Psychiatry       Date:  2016-07-12       Impact factor: 15.992

3.  Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study.

Authors:  Naruhiko Sahara; Pablo D Perez; Wen-Lang Lin; Dennis W Dickson; Yan Ren; Huadong Zeng; Jada Lewis; Marcelo Febo
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

4.  Chaperone-like manner of human neuronal tau towards lactate dehydrogenase.

Authors:  Rui Tian; Chun-Lai Nie; Rong-Qiao He
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

5.  Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method.

Authors:  H Murayama; R W Shin; J Higuchi; S Shibuya; T Muramoto; T Kitamoto
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  A possible link between astrocyte activation and tau nitration in Alzheimer's disease.

Authors:  Juan F Reyes; Matthew R Reynolds; Peleg M Horowitz; Yifan Fu; Angela L Guillozet-Bongaarts; Robert Berry; Lester I Binder
Journal:  Neurobiol Dis       Date:  2008-05-02       Impact factor: 5.996

7.  Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain.

Authors:  M Nishimura; H Tomimoto; T Suenaga; Y Namba; K Ikeda; I Akiguchi; J Kimura
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

8.  Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation.

Authors:  Jie-Jian Kou; Jun-Zhuo Shi; Yang-Yang He; Jiao-Jiao Hao; Hai-Yu Zhang; Dong-Mei Luo; Jun-Ke Song; Yi Yan; Xin-Mei Xie; Guan-Hua Du; Xiao-Bin Pang
Journal:  Acta Pharmacol Sin       Date:  2021-07-15       Impact factor: 6.150

9.  Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment.

Authors:  J R Walton
Journal:  Int J Alzheimers Dis       Date:  2012-07-30

10.  A delicate balance: Iron metabolism and diseases of the brain.

Authors:  Dominic Hare; Scott Ayton; Ashley Bush; Peng Lei
Journal:  Front Aging Neurosci       Date:  2013-07-18       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.